Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
5.76
-0.02 (-0.35%)
At close: Apr 25, 2025, 4:00 PM
5.75
-0.01 (-0.17%)
After-hours: Apr 25, 2025, 5:33 PM EDT
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $511.46 million as of April 25, 2025. Its market cap has decreased by -23.64% in one year.
Market Cap
511.46M
Enterprise Value
57.17M
1-Year Change
-23.64%
Ranking
Category
Stock Price
$5.76
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $511.46M, a decrease of -41.17%. That is a compound annual growth rate of -12.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 511.46M | 7.11% |
| Dec 31, 2024 | 477.50M | -57.41% |
| Dec 29, 2023 | 1.12B | -5.95% |
| Dec 30, 2022 | 1.19B | -32.88% |
| Dec 31, 2021 | 1.78B | 104.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.39B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |